Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Imaging Angiogenesis, Inflammation, And Metastasis In The Tumor Microenvironment With Magnetic Resonance Imaging.
S. Serres, E. R. O’Brien, N. Sibson
Published 2014 · Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
With the development of new imaging techniques, the potential for probing the molecular, cellular, and structural components of the tumor microenvironment in situ has increased dramatically. A multitude of imaging modalities have been successfully employed to probe different aspects of the tumor microenvironment, including expression of molecules, cell motion, cellularity, vessel permeability, vascular perfusion, metabolic and physiological changes, apoptosis, and inflammation. This chapter focuses on the most recent advances in magnetic resonance imaging methods, which offer a number of advantages over other methodologies, including high spatial resolution and the use of nonionizing radiation, as well as the use of such methods in the context of primary and secondary brain tumors. It also highlights how they can be used to assess the molecular and cellular changes in the tumor microenvironment in response to therapy.
This paper references
Velocity‐selective arterial spin labeling
E. Wong (2006)
Longitudinal evaluation of MPIO-labeled stem cell biodistribution in glioblastoma using high resolution and contrast-enhanced MR imaging at 14.1 tesla.
M. Chaumeil (2012)
High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging.
M. Law (2002)
Glyconanoparticles allow pre-symptomatic in vivo imaging of brain disease
S. V. van Kasteren (2009)
New approaches for imaging tumour responses to treatment
K. Brindle (2008)
Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging.
R. Weissleder (1990)
Method for intracellular magnetic labeling of human mononuclear cells using approved iron contrast agents.
J. Sipe (1999)
Distinguishing Inflammation from Tumor and Peritumoral Edema by Myeloperoxidase Magnetic Resonance Imaging
A. Kleijn (2011)
Imaging cellular markers of neuroinflammation in the brain of the rat model of amyotrophic lateral sclerosis.
D. Bataveljic (2011)
A novel human recombinant single-chain antibody targeting CD166/ALCAM inhibits cancer cell invasion in vitro and in vivo tumour growth
M. Wiiger (2010)
The impact of tumor microenvironment on cancer treatment and its modulation by direct and indirect antivascular strategies
E. Fokas (2012)
Double inversion recovery improves water suppression in vivo
J. Shen (1993)
Dynamics and fate of USPIO in the central nervous system in experimental autoimmune encephalomyelitis
Raoul D Oude Engberink (2010)
MRI of hepatic lymphoma.
R. Weissleder (1988)
DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents
J. P. O'Connor (2007)
Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma
O. Keunen (2011)
Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner.
Chunfu Zhang (2007)
Molecular MRI enables early and sensitive detection of brain metastases
S. Serres (2012)
Drug targeting in magnetic resonance imaging.
R. Weissleder (1992)
How can superparamagnetic iron oxides be used to monitor disease and treatment?
E. Unger (2003)
EGF receptor in lung cancer: a successful story of targeted therapy
G. Domingo (2010)
VCAM-1 and VAP-1 recruit myeloid cells that promote pulmonary metastasis in mice.
Špela Ferjančič (2013)
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer.
M. Harisinghani (2003)
Angiogenesis in cancer and other diseases
P. Carmeliet (2000)
Molecular Magnetic Resonance Imaging of Acute Vascular Cell Adhesion Molecule-1 Expression in a Mouse Model of Cerebral Ischemia
L. C. Hoyte (2010)
Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumours
E. Neuwelt (2004)
Mesenchymal stem cells: a potential targeted-delivery vehicle for anti-cancer drug, loaded nanoparticles.
Zibin Gao (2013)
Uptake of dextran‐coated monocrystalline iron oxides in tumor cells and macrophages
A. Moore (1997)
Macrophage Diversity Enhances Tumor Progression and Metastasis
Bin-Zhi Qian (2010)
High affinity interaction of integrin α4β1 (VLA‐4) and vascular cell adhesion molecule 1 (VCAM‐1) enhances migration of human melanoma cells across activated endothelial cell layers
M. Klemke (2007)
Tumour response prediction by diffusion-weighted MR imaging: ready for clinical use?
L. Heijmen (2012)
Cellular and vascular manifestations of cell-mediated immunity.
H. Dvorak (1986)
Monocrystalline iron oxide nanocompounds (MION): Physicochemical properties
T. Shen (1993)
Functional investigations on human mesenchymal stem cells exposed to magnetic fields and labeled with clinically approved iron nanoparticles
R. Schaefer (2009)
A theoretical and experimental comparison of continuous and pulsed arterial spin labeling techniques for quantitative perfusion imaging
E. Wong (1998)
EGFR/HER2 in breast cancer: a biological approach for molecular diagnosis and therapy
F. Milanezi (2008)
Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
K. Plate (1992)
Targeting of ICAM-1 on vascular endothelium under static and shear stress conditions using a liposomal Gd-based MRI contrast agent
L. Paulis (2012)
Patterns of epidermal growth factor receptor amplification in malignant gliomas.
G. Sauter (1996)
Noninvasive cell-tracking methods
M. Kircher (2011)
Vascular endothelial growth factor‐A determines detectability of experimental melanoma brain metastasis in GD‐DTPA‐enhanced MRI.
W. Leenders (2003)
Non-invasive assessment of tumor neovasculature: techniques and clinical applications
R. Perini (2008)
Exploiting tumour hypoxia in cancer treatment
J. M. Brown (2004)
Transplacental carcinogenesis by stilbestrol.
J. Folkman (1971)
Quantitative T2* imaging of metastatic human breast cancer to brain in the nude rat at 3 T
Hotaek Song (2011)
Colorectal cancer in review: the role of the EGFR pathway
M. Saif (2010)
EGFR gene amplification ‐ rearrangement in human glioblastomas
K. Schwechheimer (1995)
Magnetic resonance perfusion imaging in neuro-oncology
A. Jackson (2008)
In vivo imaging platform for tracking immunotherapeutic cells
E. Ahrens (2005)
Hallmarks of Cancer: The Next Generation
D. Hanahan (2011)
Comparison of quantitative perfusion imaging using arterial spin labeling at 1.5 and 4.0 Tesla
J. Wang (2002)
Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results.
T. Yankeelov (2007)
19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons
Kathryn C. Partlow (2007)
Superparamagnetic iron oxide: enhanced detection of focal splenic tumors with MR imaging.
R. Weissleder (1988)
Evaluation of Intracellular Labeling with Micron-Sized Particles of Iron Oxide (MPIOs) as a General Tool for In Vitro and in Vivo Tracking of Human Stem and Progenitor Cells
J. Boulland (2012)
New Guidelines to Evaluate the Response to Treatment in Solid Tumors.
P. Therasse (2000)
VCAM‐1‐targeted magnetic resonance imaging reveals subclinical disease in a mouse model of multiple sclerosis
S. Serres (2011)
Predicting favourable outcomes in the setting of radiofrequency catheter ablation of long-standing persistent atrial fibrillation: a pilot study assessing the value of left atrial appendage peak flow velocity.
S. Combes (2013)
MRI detection of single particles for cellular imaging.
E. Shapiro (2004)
Differential microstructure and physiology of brain and bone metastases in a rat breast cancer model by diffusion and dynamic contrast enhanced MRI
M. Budde (2011)
Anti-VEGF/VEGFR therapy for cancer: reassessing the target.
Basel Sitohy (2012)
Perfusion functional MRI reveals cerebral blood flow pattern under psychological stress.
J. Wang (2005)
High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas.
H. Aronen (2000)
Monitoring molecular, functional and morphologic aspects of bone metastases using non-invasive imaging.
Tobias Bauerle (2012)
In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide
M. McAteer (2007)
A contrast agent recognizing activated platelets reveals murine cerebral malaria pathology undetectable by conventional MRI.
C. von zur Muhlen (2008)
Ferrite-enhanced MR imaging of hepatic lymphoma: an experimental study in rats.
R. Weissleder (1987)
Magnetic resonance imaging of perfusion using spin inversion of arterial water.
D. S. Williams (1992)
Sizing it up: Cellular MRI using micron‐sized iron oxide particles
E. Shapiro (2005)
ICAM-1 expression determines malignant potential of cancer.
C. L. Roland (2007)
Magnetic Resonance Imaging of Pancreatic Islets Transplanted Into the Liver in Humans
F. Saudek (2010)
Macrocyclic chelators with paramagnetic cations are internalized into mammalian cells via a HIV-tat derived membrane translocation peptide.
R. Bhorade (2000)
Imaging angiogenesis: applications and potential for drug development.
J. C. Miller (2005)
Magnetic labeling of activated microglia in experimental gliomas.
G. Fleige (2001)
Angiogenesis in life, disease and medicine
P. Carmeliet (2005)
MRI volumetry of the vermis and the cerebellar hemispheres in men with schizophrenia
C. Joyal (2004)
Targeted signal-amplifying enzymes enhance MRI of EGFR expression in an orthotopic model of human glioma.
M. Shazeeb (2011)
Magnetically labeled cells can be detected by MR imaging
R. Weissleder (1997)
MRI of ICAM-1 Upregulation After Stroke: the Importance of Choosing the Appropriate Target-Specific Particulate Contrast Agent
L. Deddens (2013)
In vivo magnetic resonance imaging of single cells in mouse brain with optical validation
C. Heyn (2006)
Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging.
C. Warmuth (2003)
Monoclonal antibody‐coated magnetite particles as contrast agents in magnetic resonance imaging of tumors
S. Cerdán (1989)
Grading of CNS neoplasms using continuous arterial spin labeled perfusion MR imaging at 3 Tesla
R. Wolf (2005)
Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging.
A. Arbab (2003)
Dynamic contrast enhanced perfusion MRI in mycosis fungoides
M. Law (2003)
MR imaging of phagocytosis in experimental gliomas.
C. Zimmer (1995)
In vivo MRI of cancer cell fate at the single‐cell level in a mouse model of breast cancer metastasis to the brain
C. Heyn (2006)
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability.
F. Colotta (2009)
MR imaging of splenic metastases: ferrite-enhanced detection in rats.
R. Weissleder (1987)
Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response.
B. Moffat (2005)
Imaging in the era of molecular oncology
R. Weissleder (2008)
Cerebral iron oxide distribution: in vivo mapping with MR imaging.
C. Zimmer (1995)
Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity
D. DeNardo (2010)
Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings.
H. Aronen (1994)
Sensitive, Noninvasive Detection of Lymph Node Metastases
M. Harisinghani (2004)
Angiogenesis as a therapeutic target
N. Ferrara (2005)
Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.
M. Law (2003)
Rapid detection and simultaneous molecular profile characterization of Acanthamoeba infections.
P. Goldschmidt (2012)
Protein expression analysis of ALCAM and CEACAM6 in breast cancer metastases reveals significantly increased ALCAM expression in metastases of the skin
M. Ihnen (2011)
Cilengitide inhibits progression of experimental breast cancer bone metastases as imaged noninvasively using VCT, MRI and DCE‐MRI in a longitudinal in vivo study
T. Bäuerle (2011)
The Vascular Basement Membrane as “Soil” in Brain Metastasis
W. Carbonell (2009)
In‐vivo visualization of phagocytotic cells in rat brains after transient ischemia by USPIO
M. Rausch (2002)
MR imaging of focal splenic tumors.
P. Hahn (1988)
Selectins promote tumor metastasis.
H. Läubli (2010)
Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil.
C. W. Jung (1995)
Radiological progression of cerebral metastases after radiosurgery: assessment of perfusion MRI for differentiating between necrosis and recurrence
F. Hoefnagels (2009)
MRI & MRS assessment of the role of the tumour microenvironment in response to therapy
L. Bell (2011)
Internalization of paramagnetic phosphatidylserine-containing liposomes by macrophages
T. Geelen (2012)
A general kinetic model for quantitative perfusion imaging with arterial spin labeling
R. Buxton (1998)
Noninvasive monitoring of orthotopic glioblastoma therapy response using RGD-conjugated iron oxide nanoparticles.
F. Zhang (2012)
Metastasis: from dissemination to organ-specific colonization
D. Nguyen (2009)
Tumor angiogenesis: therapeutic implications.
J. Folkman (1971)
In vivo MRI tracking of exogenous monocytes/macrophages targeting brain tumors in a rat model of glioma
S. Valable (2007)
Automated tracking of nanoparticle-labeled melanoma cells improves the predictive power of a brain metastasis model.
Terje Sundstrøm (2013)
Magnetic resonance imaging of immune cells in inflammation of central nervous system.
I. Pirko (2003)
Molecular MR imaging of melanoma angiogenesis with ανβ3‐targeted paramagnetic nanoparticles
A. Schmieder (2005)
Acute ischemic stroke: predictive value of 2D phase-contrast MR angiography--serial study with combined diffusion and perfusion MR imaging.
Y. Liu (2004)
Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy
I. J. Vries (2005)
Abnormal Intravoxel Cerebral Blood Flow Heterogeneity in Human Ischemic Stroke Determined by Dynamic Susceptibility Contrast Magnetic Resonance Imaging
J. Perkiö (2005)
Systemic Inflammatory Response Reactivates Immune-Mediated Lesions in Rat Brain
S. Serres (2009)
Reduced Transit-Time Sensitivity in Noninvasive Magnetic Resonance Imaging of Human Cerebral Blood Flow
D. Alsop (1996)
Quantitative estimation of microvascular permeability in human brain tumors: correlation of dynamic Gd-DTPA-enhanced MR imaging with histopathologic grading.
H. Roberts (2002)
This paper is referenced by
Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model.
R. Pachynski (2015)
Interrogating Metabolism in Brain Cancer.
T. Salzillo (2016)
NLRP3 inflammasomes in macrophages drive colorectal cancer metastasis to the liver.
Qiaoting Deng (2019)
Predicting Long Term HCC Response to Radioembolization Using Contrast-Enhanced Ultrasound 1-2 Weeks Post Treatment
Lauren J Delaney (2019)
OKN-007 decreases VEGFR-2 levels in a preclinical GL261 mouse glioma model.
Patricia Coutinho de Souza (2015)
Imaging the Tumor Microenvironment.
Valerie S LeBleu (2015)
Nano‐sized and other improved reporters for magnetic resonance imaging of angiogenesis☆
S. G. Crich (2017)
Complex metastatic niches: already a target for therapy?
P. Ordóñez-Morán (2014)
Multimodal magnetic resonance imaging evaluation of primary brain tumors.
D. Treister (2014)